The RICORDO approach to semantic interoperability for biomedical data and models: strategy, standards and solutions by Bernard de Bono et al.
SHORT REPORT Open Access
The RICORDO approach to semantic
interoperability for biomedical data and models:
strategy, standards and solutions
Bernard de Bono1,3*, Robert Hoehndorf 2, Sarala Wimalaratne1, George Gkoutos2 and Pierre Grenon1
Abstract
Background: The practice and research of medicine generates considerable quantities of data and model
resources (DMRs). Although in principle biomedical resources are re-usable, in practice few can currently be shared.
In particular, the clinical communities in physiology and pharmacology research, as well as medical education, (i.e.
PPME communities) are facing considerable operational and technical obstacles in sharing data and models.
Findings: We outline the efforts of the PPME communities to achieve automated semantic interoperability for
clinical resource documentation in collaboration with the RICORDO project. Current community practices in
resource documentation and knowledge management are overviewed. Furthermore, requirements and
improvements sought by the PPME communities to current documentation practices are discussed. The RICORDO
plan and effort in creating a representational framework and associated open software toolkit for the automated
management of PPME metadata resources is also described.
Conclusions: RICORDO is providing the PPME community with tools to effect, share and reason over clinical
resource annotations. This work is contributing to the semantic interoperability of DMRs through ontology-based
annotation by (i) supporting more effective navigation and re-use of clinical DMRs, as well as (ii) sustaining
interoperability operations based on the criterion of biological similarity. Operations facilitated by RICORDO will
range from automated dataset matching to model merging and managing complex simulation workflows. In
effect, RICORDO is contributing to community standards for resource sharing and interoperability.
Background
Data and model resources (DMRs) in biomedical
research and practice cover a wide range of electronic
resource types. In the medical regulatory and clinical
domain, for example, drug development trials and patient
management practice generate considerable amounts of
free-text notes, investigative, analytic and interventional
results in tabulated form, various types of image data,
mathematical models, as well as associated training and
teaching material. The output of basic biological research
(e.g. drug discovery, tissue biophysics, genomics) is com-
parably broad and heterogeneous.
The biomedical community is becoming increasingly
aware of the importance of DMR standardization, sharing
and publication [1]. In turn, a number of funding bodies
have established relevant policies in support of a co-ordi-
nated communal DMR sharing strategy (e.g. see [2-6]). In
particular, the standardization of DMR documentation is
fundamental in supporting resource sharing - in principle,
the documentation of a resource renders it more accessible
to interpretation and consequently encourages its further
re-use and interoperability with other resources. In prac-
tice, however, the procedure of applying DMR documenta-
tion is typically considered to (i) be very time-consuming,
and (ii) able to offer only limited support for resource
interoperability (e.g. see background section of [7]).
In the physiology modeling community, for instance,
the documentation and systematic annotation of DMRs
is known to face a number of obstacles [8]. For example,
due to the relative lack of familiarity with (i) controlled
biomedical vocabularies and their key role in DMR
annotation, as well as (ii) associated tools that support
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the automated organization and classification of DMRs,
this research community finds little practical incentive
to take on the logistic challenge exacted in documenting
DMRs over a large scale. A common concern (in discus-
sion with the physiology modelling community by one
of us, BdB personal communication) about such docu-
mentation argues that there is little in the way of com-
munal annotation standards to justify the investment
required. In addition, the effort employed by biomedical
communities in providing detailed annotation to a DMR
tends to be closely influenced by the expectation of a
resource being shared [7]. Therefore, the limits imposed
on the distribution of a resource (typically for commer-
cial, legal, confidentiality, but also interoperability, rea-
sons) tend to curb directly the quality and machine
readability of the corresponding documentation: after
all, why document a DMR if the resource cannot (or
will not) be accessed by third parties?
The issues outlined above present a formidable obstacle
to the communal provision and standardization of DMR
documentation in the clinical domain. This paper reports
on the ongoing effort to achieve a coherent DMR docu-
mentation methodology by three distinct clinical commu-
nity initiatives in collaboration with the RICORDO
project [9]. The three community initiatives are:
1. the Virtual Physiological Human (VPH) Network
of Excellence [10], which aims to apply biomedical
research outputs into clinical practice and healthcare
industries [11]. In particular, this community fosters
the integration of clinical data and models for research
purposes in an effort to gain a systemic understanding
of pathophysiology and to develop clinical diagnostic
tools and medical devices.
2. the Innovative Medicines Initiative (IMI) [12,13],
and in particular the ‘Drug & Disease Modeling
Resource’ (DDMoRe) [14] community of modellers in
academia and Pharma industry. The aim of the
DDMoRe is the creation of a communal infrastructure
for model based-drug development by (i) facilitating
the continuous integration of available information
related to a drug or disease, as well as (ii) supporting
the rational management of modelling and simulation
workflows.
3. the mEducator Best Practice Network (mBPN)
[15], that aims to implement and critically evaluate
existing standards and reference models in the field
of e-learning in order to enable specialized state-of-
the-art medical educational content to be discovered,
retrieved, shared and re-used across European higher
academic institutions.
Communities in the three domains described above -
physiology and pharmacology research, as well as
medical education (PPME) - share the objective of
managing heterogeneous clinical DMRs based on their
biological meaning. The ability to search and compare
datasets, and associated models, based specifically on
their biological knowledge content would (i) support
more effective navigation and re-use of clinical DMRs,
as well as (ii) sustain automated interoperability opera-
tions based on the criterion of biological similarity and
relatedness. Such automated operations include activities
ranging from dataset matching, to model merging, and
managing complex simulation workflows.
The biological meaning of a resource may be described
by its documentation. The management of automated
DMR operations in terms of biological meaning, there-
fore, depends on this documented biological knowledge
being explicit and machine readable. In that sense, when
a set of clinical DMRs can be consistently related and
navigated through explicit meaning in the documenta-
tion, such a set may said to be semantically interoper-
able. In addition, when this explicit meaning is machine
readable, semantic interoperability operations may be
carried out in an automated manner.
In this paper, we outline the efforts of the PPME com-
munities to achieve automated semantic interoperability
for clinical DMR documentation in collaboration with
the RICORDO project. We first briefly overview current
community practices in resource documentation and
knowledge management. We then discuss the require-
ments and improvements sought by the PPME commu-
nity to the above documentation practices and
associated knowledge representation. We then present
how the RICORDO community effort addresses the key
challenges in creating a representational framework and
associated infrastructure for the management of PPME
DMRs. In particular, the Results section introduces an
ontology-based knowledge representation framework
and associated tools that are being developed for the
biological annotation and organization of DMR docu-
mentation. Furthermore, we show how the RICORDO
framework will facilitate the automated management of
clinical DMRs based on the biological meaning of
resources.
How do the PPME communities currently manage the
biological documentation of DMRs?
In the PPME communities discussed above, clinical DMR
documentation is typically carried out at individual project
or study level (e.g. [16]). In many cases, this documenta-
tion is effected by the same project participants who gen-
erated the resource in the first place, in the form of free-
text labels associated with DMR elements [8] (see also
Figure 1A). Examples of elements in clinical DMRs
include (i) a data column in a clinical trial spreadsheet or
database table, (ii) a variable in the code of a physiology
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model, (iii) a specific spatial region in a radiology image, or
(iv) a pathology term in a flat list of disease names.
Free text labels associated with clinical DMRs carry
with them a considerable baggage of implicit biomedical
knowledge. Phrases used for free-text labelling vary
between different PPME communities and the standardi-
zation of such phrases is particularly difficult if the
DMRs containing such labels are not shared. In some
cases, text mining techniques may assist in relating
DMRs based on their label content (see Figure 1A), but
such approaches have significant limitations without the
use of independent reference knowledge structures [17].
The past decade saw an increased community effort in
developing independent reference knowledge structures
as a means to standardize the representation of biological
meaning in DMRs (e.g. [18]), and to render DMR docu-
mentation more machine processable and interpretable
(e.g. [19]). Two key advances in DMR documentation
Figure 1 Comparing biological meaning associated with data and model resource (DMR) elements. A. Free-text labels associated DMR
elements that convey human-readable meaning (e.g. text label associated with a data column in a spreadsheet) are a very common method of
documentation. Text mining methods can assist with finding relationships between text labels, but may encounter difficulties in identifying
closely related concepts expressed using different words: for example the labels “Blood Flow to the Lungs” and “Pulmonary Cardiac Output”
have very similar meaning but their textual representation is very divergent. B. Controlled vocabularies provide a standard set of Uniform
Resource Identifiers (URIs) with which relevant biomedical concepts may be unambiguously associated. For example, while each of the two
elements carries a distinct free-text label, their metadata mappings to the same controlled vocabulary term (with ID#1:1234) makes it explicit that
the annotations associated with the two DMR elements are semantically identical (i.e. are synonymous). C. Ontologies provide explicit machine
readable knowledge about relationships between terms. The above example illustrates the hierarchy of parts of the heart. By explicitly
representing knowledge as well-defined concept nodes and relation edges between such concepts, it is possible to compare DMR metadata
associated with concepts from the same ontology precisely and automatically. D. Part of the RICORDO effort is to provide tools for the
annotation of DMR metadata with composite ontology structures. A composite term consists of two or more ontology terms in which the
relationship between such terms is explicitly represented within the composite knowledge structure. Such composites may be compared on the
basis of the terms that compose them - for instance, the two composites depicted in this diagram may be compared, using classification tools,
on the basis of the ontology terms for cardiac structure (#2: red) and biological qualities (#3: blue) from which they are derived.
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management and semantic interoperability were the
development of:
1) Community semantic metadata standards and
associated tools;
Metadata refers to machine readable documentation
material that is linked to a corresponding DMR ele-
ment indicating how the actual content of that ele-
ment should be interpreted. Semantic metadata
ascribes a DMR element with some meaning. By expli-
citly representing the meaning of a DMR element, this
type of metadata adds semantic features to a resource
and provides a machine readable and independent
guide as to what a particular DMR element represents.
The goal of achieving semantic interoperability for a
set of DMRs is motivated by the need to automate the
coherent interpretation of DMR content over a large
number of diverse DMRs. A key result of attaining this
goal is the ability to automatically identify DMRs that
are related to each other solely on the basis of their
metadata documentation notwithstanding any differ-
ences in format, accessibility or ancillary free-text
labels the various DMRs may have. The automation of
semantic interoperability requires a dedicated compu-
tational infrastructure (e.g. [20-22]).
2) Controlled vocabularies and ontologies (CVOs);
CVOs are independent knowledge structures used by
the community to provide a standardized set of terms
with which to annotate DMR metadata. An example
of an annotation using CVOs is shown in Figure 2. In
some cases, simple vocabularies are primarily devel-
oped to (i) support human readability of metadata
and (ii) provide a stable set of Uniform Resource
Identifiers (URIs) for annotation. Examples of such
terminologies consist of either a flat list (e.g. CDISC
terminology [23]) or a single hierarchy (e.g. MedDRA
[24]) of standard terms controlled via some editorial
process to avoid semantic redundancy and overlap
Figure 2 An example of an annotation triplet in the metadata of a model resource. Example illustrating the structure of a typical model
resource A (in this case, an SBML model) in which element B is shown to bear (i) a human-readable text label G, as well as (ii) machine-readable
metadata C. The annotation triplet is composed of a DMR element URI (D), a relation (F), and an ontology URI (E). In the above example, the
annotation in the metadata conveys the meaning that the model’s reaction with the Unique Resource Identifier (URI) 230655 (D) occurs in (F)
the anatomical location identified by URI FMA_9477 (E). The latter URI represents the sinoatrial node term in the Foundational Model of
Anatomy [29].
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(hence the use of the phrase ‘controlled vocabulary’).
Compared to flat-list terminologies, biomedical
ontologies aim to render the meaning of their terms
explicit and amenable to machine processing and
automated reasoning [25]. Ontologies are therefore a
more knowledge-rich means by which to standardize
the terms used in a domain and to render their mean-
ing explicit. Considerable progress has been made in
developing reference ontologies for key domains in
biology, including gene functions and processes [26],
chemical entities [27], proteins [28], anatomy [29]
and phenotypes [30].
Controlled vocabulary flat lists offer some scope for
automated processing of knowledge embedded in DMR
metadata (see Figure 1B). However, ontologies provide a
more detailed representation of relationships between
concepts over which DMR metadata may be classified
and compared (Figure 1C) [25]. This classification pro-
cess of automated traversing of, and inference from, this
type of knowledge graph is sometimes referred to ‘rea-
soning over an ontology’. This type of automated rea-
soning is simply not possible with list-based controlled
vocabularies.
While the use of CVOs in providing stable identifiers
for semantic metadata annotation (exemplified by Figure
1B) has contributed significantly to standardizing DMR
documentation methodologies (e.g. [18]), this approach
is still beset by two key limitations:
1) Some CVOs may overlap in their knowledge
domain without being semantically interoperable;
Different PPME communities may adopt different
CVOs as standard for DMR metadata annotation.
However, no explicit mapping between semantically
overlapping terms in the distinct CVOs may exist.
For example, without an appropriate mapping
between MedDRA and CDISC terminologies (e.g. via
metathesaurii like UMLS [31]), it is difficult to auto-
matically infer that both the MedDRA Lower-Level
Term ‘Itchy Rash’ and the CDISC CodeList Name
‘Skin Classification’ relate to some property of the
skin. If this is the case, then DMR metadata that
bears CDISC terms may not be semantically intero-
perable with DMR metadata using MedDRA terms in
an automated manner. This lack of semantic intero-
perability may present a serious problem with the
exploitation of legacy data if heterogeneous standards
were applied to DMR documentation metadata.
2) Technical issues with reasoning over large
ontologies;
Although, in principle, ontologies provide an explicit
graph structure over which DMR metadata may be
compared, in practice the complexity of large reference
ontologies (e.g. ontologies for biomedically-relevant
small molecules, human anatomy etc.) may lead to ser-
ious computational performance limitations. These
technical limitations often prove to be a formidable
obstacle for small isolated PPME communities to ben-
efit from complex knowledge structures. When ontol-
ogy reasoning is not applied, the role of an ontology in
supporting semantic interoperability of resources
tends to be reduced to that of a flat-list controlled
vocabulary that provides stable IDs for direct metadata
comparisons (i.e. ontology terms are used for direct
ID-to-ID matching shown in Figure 1B rather than for
the type of reasoning illustrated in Figure 1C).
How may the current documentation standards and
management of clinical DMRs be improved?
In identifying the above limitations in the utilization of
CVOs for DMR metadata annotation, the RICORDO
effort was able to compile the following key PPME com-
munity requirements to improve metadata management
and semantic interoperability of clinical resources:
1) A communal metadata annotation standard
should aim to use CVOs that minimize the chance of
knowledge domain overlap;
A number of terminologies and ontologies have been
developed to address some particular representational
requirement in biomedicine (see portals at the NCBO
[32] and OBO Foundry [18]). Some of these CVOs
overlap in the domain of knowledge they represent.
The establishment of a DMR annotation standard
should aim to minimize such overlap. When such
overlap is inevitable, appropriate computational ser-
vices should map CVOs that are semantically intero-
perable. In view of the richer knowledge structures
ontologies are able to provide, a communal metadata
annotation standard should ideally identify relevant
biomedical ontologies that are supported and main-
tained by the community.
2) CVOs used for DMR annotation should be seman-
tically interoperable;
Elements in PPME resources often represent very
complex concepts (e.g. processes in physiology). The
development and maintenance of CVOs that cover
complex domains is a demanding process that
requires significant support and input from the com-
munity (e.g. see [33-37]). The complexity of this
operation may either (i) prevent altogether the con-
struction of an appropriate CVO to cover a particular
domain of knowledge, or (ii) lead to the divergent
development of overlapping CVOs without provision
for automated semantic interoperability between
them. In either case, standard methods and relevant
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tools should be provided to make use of existing
ontologies in support of (i) filling gaps in domain
knowledge representation and (ii) establish explicit
semantic mappings between existing CVO terms
respectively.
3) A communal PPME metadata toolkit is required
to effect, share and reason over ontology-based
annotations;
A complementary set of tools is required to support
annotation authoring, storage and querying. Authoring
tools are required by users in the community to effect
annotations on the DMRs they generate - such tools
could be web-based for ease of access. In this context,
the annotation process requires access to (i) DMR ele-
ment identifiers, (ii) annotation relationships, as well
as to (iii) ontological terms for annotation. It is also
envisioned that annotation storage, update and lookup
functionalities should be web-based. This imposes
hardware requirements on the prospective implemen-
tation of an infrastructure to deploy the applications
and related data over the web. The query step is
required to reason over complex ontologies in order to
relate DMR annotations with respect to these indepen-
dent knowledge structures - this aspect of the infra-
structure is therefore required to provide a level of
performance that is appropriate for an interactive
query.
4) A common format for DMR annotation needs to
be established;
If an annotation framework is to be applied to hetero-
geneous resources it is required to support the intero-
perability of annotations: when brought together,
annotations of distinct resources need to be manage-
able as would annotations of a single resource. Syntac-
tic homogeneity of annotation facilitates the machine
readability and uniform interpretation of resource
metadata. To this end, for example, the community in
the systems biology domain is addressing this goal by
introducing a common format for annotating their
data and models. The Minimal Information Required
In the Annotation of Models (MIRIAM) is a set of
guidelines for annotation and curation processes of
computational models to facilitate their exchange and
reuse [38]. A number of VPH resources are already
annotated using MIRIAM, such as SBML [39] and
CellML [40]. The Model Format OWL (MFO) is
another effort within the systems biology community
that is focused on data integration by capturing the
SBML structure of biological annotations in OWL-DL
to support reasoning, validation, and querying of
SBML models [41]. The PPME community should
build upon such efforts when establishing communal
annotation standards.
5) A PPME toolkit should support community meta-
data catalogues;
PPME resources are encoded over a wide range of
formats and are subject to a variety of constraints on
their distribution to the rest of the community. A
communal PPME annotation framework should
ensure the structural integrity and security con-
straints of clinical DMRs. The provision of metadata
catalogues that allow the uncoupling of annotation
distribution from that of their corresponding resource
is a strategy that has been successfully adopted by
clinical communities (e.g. [7,20]). In other words,
PPME annotations would be accessible as a catalogue
for querying by third parties, without having to neces-
sarily provide access to the original models or data-
sets being catalogued. For example, within a Pharma
company, a clinical department may serve a catalogue
describing clinical trial data holdings without neces-
sarily providing access to the actual data repositories
to unauthorised personnel. Furthermore, the uncou-
pling of metadata from their corresponding resource
has the additional benefit of protecting the integrity
of DMRs. No significant change to the format of a
DMR may be required if related metadata can be
stored in a separate file as long as it holds a mapping
to the DMR element URIs. This approach may there-
fore provide a viable semantic interoperability solu-
tion despite the inevitable heterogeneity of resource
formats: for instance, cardiac physiology models writ-
ten in different programming (or markup) languages
may share the same metadata standard along with
radiological datasets of the heart (which may also be
stored over a number of heterogeneous formats).
The scope of the RICORDO effort
The practice, education, research and industrialization of
biomedicine generate large quantities of data, often at
great risk or expense. In addition, the study and interpre-
tation of this data typically employs the use of mathema-
tical models based on discrete (e.g. statistical) or
continuous (e.g. infinitesimal calculus) methods. In turn,
the validity and robustness of a model, and the results it
produces, largely depend on the quality and quantity of
data that is applied in its construction and usage. One of
the key biomedical research applications of semantic
interoperability, therefore, is to help the PPME commu-
nity find datasets (stored in apposite repositories such as
[42]) that are relevant to their modelling and educational
goals. Ideally, having found the relevant datasets, the
same interoperability framework would be transferable to
the workflow that handles data and model interaction.
When the same semantic metadata standards are applied
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across the board, both datasets and models achieve
semantic interoperability. Achieving automated semantic
interoperability across the board of clinical data and
models is the scope of the RICORDO effort.
The biologically meaningful co-ordination of mathe-
matical modelling and data resource management in the
PPME domains requires semantic interoperability
between the metadata of clinical models and datasets.
To this end, and with reference to the PPME commu-
nity requirements outlined in the previous section, the
RICORDO effort is designing and implementing a
semantic interoperability framework over two fronts:
a) The first priority is to contribute to a community
standard for:
i. the use of communal and non-overlapping
reference ontologies as a source of unambiguous
and uniquely identifiable terms and relations for
DMR element metadata annotation (Figure 3A);
ii. the well defined representation and encoding
of uniquely traceable metadata in which annota-
tions are embedded.
b) The second priority addresses the development of
an open toolkit to:
i. support the representation of complex biome-
dical concepts using terms from standard refer-
ence ontologies (known as ontology composites),
thus supporting community efforts to fill gaps in
the knowledge domain (such as physiology and
pharmacology - see ‘Key issues’ section below)
and to improve the semantic interoperability of
existing CVOs (Figure 3B);
ii. annotate DMR metadata and to enable the
sharing of annotation triplets that are generated
by this process (Figure 4A). The distribution of
annotations may be uncoupled from the accessi-
bility or format restrictions that may be applic-
able to their corresponding DMRs;
provide services in support of querying repositories
of annotations through efficient automated reasoning
over the standard reference ontologies (and their
composites) from which annotation terms are
derived (Figure 4B).
Key issues for complex knowledge biomedical
representations in physiology and pharmacology
As a field of research, ‘physiology’ studies the physical
principles that govern the behaviour of anatomical
structures within processes of medical relevance. This
effort overlaps considerably with that of ‘pharmacology’
and ‘systems biology’. As a domain of knowledge that
functionally bridges anatomy-level structures to pro-
cesses (typically through the application of physics), the
physiology domain is also sought to provide a clinical
knowledge framework that links anatomical abnormal-
ities with pathological processes.
Clinical terms from pharmacology and physiology are
employed by the biomedical community to annotate
DMRs that are relevant to drug development and clini-
cal practice respectively. A significant proportion of
such terms (e.g. ‘cardiac output’, ‘blood pressure’) refer
to canonical notions of biological structure (e.g. anat-
omy, molecular architecture) and process (e.g. drug
action, physiological mechanisms), whilst others refer to
pathological deviations from anatomical (e.g. aortic
aneurysm) and processual (e.g. respiratory failure)
norms [43].
Clinical terms carry significant implicit clinical knowl-
edge and cannot easily be interpreted by non-experts or
machines. For instance, the close biological similarity of
the terms ‘cardiac angina’ and ‘intermittent claudication’ -
both involve pain due to the process of ischaemia that is
usually the result of underlying atherosclerosis - may not
be immediately obvious. Similarly, it may be difficult for a
non-expert to interpret and relate terms such as ‘renal
clearance’, ‘cystometric capacity’ and ‘venous return’. In
this particular example, ‘cystometric capacity’ and ‘venous
return’ both represent the notion of volume of some biolo-
gical structure (urinary bladder in the former and blood in
the latter), ‘renal clearance’ and ‘venous return’ both refer
to first derivatives with respect to time, while ‘renal clear-
ance’ and ‘cystometric capacity’ both describe some func-
tional aspect of the urinary tract.
The above examples show that clinical terms may be
implicitly related to one-another in a number of ways. A
key step in rendering the knowledge represented by
clinical terms explicit is to map the terms to a formal
knowledge representation language that enables the
description of canonical notions of biological structure
and process. Ontologies provide an explicit representa-
tion of biological knowledge and biological concepts
through axioms and definitions [44]. By mapping clinical
terms to reference concepts in ontologies, it is possible
to search, relate and classify such terms on the basis of
the explicit and formal features described in the ontolo-
gies (see Figure 1D for an example).
While considerable progress has been made in develop-
ing reference ontologies for key domains in biology, so far,
no significant reference ontology or terminology for the
domain of physiology has been developed. The key chal-
lenges for developing a physiology ontology are in the
diversity of the knowledge required to formulate key phy-
siological representations. In addition, the domain of phy-
siology is complex and multi-dimensional, combining
domains from the molecular to the organismal level of
granularity. Furthermore, physiological phenomena
require a complex conceptualization.
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(A)
(B)
Figure 3 An example of an annotation triplet in the metadata of a model resource. (A) Overall schematic representation of the key
aspects of semantic interoperability in which annotations provide a link between DMR observations and ontology-based meaning. (B) A detail
of reference ontology structure representing explicit knowledge. The section of the Biological Qualities ontology only makes use of the
subsumption relation. The Anatomy ontology also uses the partonomy relation. Note that, while composite terms have their own unique
identifier, they still explicitly refer to Uniform Resource Identifiers (URIs) of standard reference ontologies. In the RICORDO project, both standard
reference ontologies and composite terms are formalized in OWL.
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(A)
(B)
Figure 4 An example of an annotation triplet in the metadata of a model resource. (A) An example illustrating the role of semantic
metadata in support of the semantic interoperability for a set of DMRs. Note that the DMRs may have different formats to encode their
scientific content. However, for automated semantic interoperability to be possible between this set of DMRs (bottom layer), the encoding of the
semantic metadata content must ideally be in the same language and format. A second key requisite is that the DMR metadata must make use
of the same set of reference ontologies for its semantic content. Note how, in the case of the ‘Reference List of Pathology Terms’, a single
element URI (yellow dot) is the subject of three distinct annotations to three ontology term URIs. In this particular example, a pathology entity is
related to the (i) size quality of (ii) endothelial cells in (iii) the liver - linking the pathology entity URI via distinct relations to URIs respectively
from PATO (biological qualities) [45], CellType [67] and FMA (gross anatomy) [29]. That same DMR element (shown as a grey box) is also
associated with an independent free-text label (pink dot). While human-readable, this label is not machine interpretable. In the RICORDO
infrastructure the Annotation Repository referred to in this diagram is implemented as an RDF Triple Store. (B) RICORDO annotations of DMRs
using terms from standard reference ontologies and their composites. The DMR management architecture supports the querying of the
repository of annotations using ontology terms as well as composites constructed ad hoc for a particular search. Query_1: the RICORDO
infrastructure supports the search for any annotation that involves ontology terms that are a type digestive organ by reasoning over the
subsumption relations. This query takes as input the anatomy ontology URI for Digestive Organ (URI: 5). Results: (i) DMR [A] element that
represents a pancreatic region on a CT image; (ii) DMR [C] element that bears a clinical trial vocabulary term (e.g. the ‘Small Intestine’ term from
‘Anatomical Location’ CDISC codelist); and (iii) DMR [E] element on the volume of the pancreas. Query_2 supports queries that search for
annotations to all known vascular organs and their parts. This query takes as input the anatomy ontology URI for Vascular Organ (URI: 6) and
returns: (i) DMR [B] element pertaining to the a surgical procedure report about the mitral valve; (ii) DMR [D] element for an cardiac echo
Doppler; and (iii) DMR [F] for a medical record about the flow of blood from the patient’s central veins to the right atrium. The latter concept is
represented as a composite of standard reference ontology terms. Query_3 asks the following questions: ‘Are there annotations that explicitly
describe the size of organs?’ The ad-hoc creation of a composite construct that refers to the size that pertains to all known organ subclasses and
parts allows the RICORDO framework to ask this question. Results: DMR [D] as well as DMR [E]. Both ‘Area’ and ‘Volume’ are subclasses of ‘Size’ in
the quality ontology. ‘Pancreas’ is a subclass of ‘Organ’, while ‘Mitral Valve’ is a part of the ‘Organ’ subclass ‘Heart’.
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By mapping clinical terms onto biological concepts
in ontologies, it is possible to search, relate and classify
such terms on the basis of the independent context the
ontology graphs provide (see Figures 1D and 4B). A
more unified and explicit representation of clinical
terms, and by extension disease terms, may therefore
be achieved if they were also mapped to standard
reference ontologies built by experts in physics, biolo-
gical processes and structural biology. The RICORDO
project aims to use standard reference ontologies
maintained by the OBO community [18] as the source
of concepts with which to describe complex clinical
phenomena. This approach sets the stage for the phy-
siology and pharmacology community to benefit from
some of the successes already achieved by the molecu-
lar and systems biology community in the biological
integration of their DMRs through the use of ontolo-
gies (e.g. [18,26,45]).
Results
RICORDO makes use of an interoperability strategy,
based on the use of standard reference ontologies,
initiated by the molecular [26] and systems biology [46]
communities. In the RICORDO framework, terms from a
core set of biomedical reference ontologies [18] that con-
vey biological meaning are embedded in DMR metadata.
For ontology-based interoperability solutions for
DMRs to be adopted by industrial and clinical commu-
nities, significant progress needs to be achieved, and
demonstrated in practice, in effecting, sharing and rea-
soning over annotations. To this end, RICORDO is
developing a toolkit that supports community annota-
tion and interoperability requirements discussed pre-
viously (see also published project reports [47-50]). In
this section, we discuss the results achieved so far in
developing the RICORDO framework.
(a) Ontologies for annotation
(a.1) Ontology standards
The goal of achieving semantic interoperability for DMRs
in specific domains of biological knowledge leads to the
following question: which biological ontologies should be
used for DMR annotation? Ideally, the selected ontolo-
gies should be (i) well established, (ii) actively supported
by the community, and (iii) already being applied in the
annotation of biomedical resources in the public domain.
Such ontologies would therefore provide the meaning
with which to manage considerable biomedical resources
already available in the public domain. Furthermore,
ontologies that are held as reference standard by the
community are more likely to add substantial knowledge
to DMRs that are annotated using their terms.
To this end, the initial RICORDO effort has identified a
first set of reference ontologies that represent biological
structure across multiple scales, starting from small
molecules (e.g. glucose from ChEBI[51]) and reaching
gross anatomical level (e.g. spleen from the FMA[29] -
see published report [52] for further details). These
ontologies have minimal overlap between each other, and
their development and maintenance is driven by the
community (following OBO principles [18]). A second
set of ontologies has been selected to cover biological
qualities observed in the lab or clinic (e.g. pressure, mass,
concentration etc.), biological processes, as well as units
of measurement [51].
(a.2) A grammar to build composite complexes from basic
ontology terms
While well-developed reference ontologies are readily
available to describe basic biological concepts (e.g. struc-
ture, processes and their qualities) in a consistent man-
ner, most biomedical data and models tend to represent
more complex concepts as well. An example of a com-
plex concept from physiology is ‘venous return’, which
refers to the rate of blood flowing from the central sys-
temic veins back to the right atrium of the heart. In such
a case, no single ontology from the above reference sets
can provide a term that completely and explicitly repre-
sents the precise meaning of that semantic entity.
In this context, the relevant questions that RICORDO
is addressing are: “(i) Could terms from basic reference
ontologies be combined into a composite structure that
conveys such a complex meaning? (ii) Could such a
composite term still be used for annotation and query
purposes?”
To address these questions, RICORDO is developing a
grammar (and is implementing a corresponding compo-
site term editor - see Toolkit section below) that draws
upon terms from basic reference ontologies to create
composite representations of complex biological con-
cepts (see Figure 3B for an illustration of the grammar as
applied to “venous return”, as well as [53]). The key
advantage of the composite approach is that complex
concepts retain a mapping to reference ontology terms in
a systematic and consistent manner (see also published
report [54]).
(b) Metadata standards for annotation with ontology
terms
The process of annotation renders knowledge about
DMR elements more explicit. For the purpose of seman-
tic interoperability in RICORDO, this annotation is car-
ried out using standard reference ontology terms or their
composite constructs (as described above).
The manner by which annotations are embedded in
DMR semantic metadata is a crucial aspect of the anno-
tation process. The metadata standard specifies the pre-
cise syntax and semantics that relate a DMR element to
the terms or composite constructs that are chosen to
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represent its meaning. This standard is also critical in the
development of protocols (and, therefore, tools) that
effect and parse DMR annotation metadata. In addition,
metadata standards for DMRs carry considerable implica-
tions as to how annotations may be stored and shared (i)
within the confines of a single organization or, indeed,
(ii) with the rest of the community in the public domain.
In RICORDO, annotation-bearing metadata is encoded
using the Resource Description Framework (RDF), which
has a serialisation in the Extensible Markup Language
(XML). RDF is adopted to provide traceable links to tri-
plets of DMR element and ontology concept URIs. These
triplets are then collected into an apposite RDF reposi-
tory and queried using the RDF query language (SPARQL
[55]). This strategy can be combined with existing anno-
tation standards such as MIRIAM [38]. RICORDO is
implementing an annotation tool that generates such
RDF statements - see Toolkit section below.
(c) Automated reasoning and inference over annotations
It is essential that the expense and commitment invested
by an organization to adopt community-wide ontology
and metadata standards for annotation is amply matched
by the returns of improved DMR interoperability and
searchability. Consequently, the contribution of reference
ontologies to interoperability ideally should:
(i) exceed the mere provision of an identifier name-
space, and
(ii) contribute to the inference of semantic similarity
of DMR elements in a manner that is based on much
more than the simple matching of identical annotations.
A more productive semantic interoperability approach
takes full advantage of the knowledge captured by the (i)
reference ontologies, and (ii) DMR annotations, on the
basis of well-defined ontological relationships. The use of
OWL-based reasoning tools (such as Pellet [56]) in such
approaches would carry out logical operations over the
graph structure of ontologies in support of the automated
classification of DMR annotations (see published report
on the RICORDO prototype we have developed that
makes use of such reasoning tools [50]).
To this end, a key requirement of the OWL-based
RICORDO reasoning module is to provide efficient per-
formance in its inferences over ontologies of substantial
combined size and complexity such as the FMA and
ChEBI. The reasoning module we have developed is clo-
sely linked to the RDF store that houses annotation tri-
plets (see Figure 5), and the role of the reasoner is to
generate the list of relevant ontology terms with which
to search the RDF triple store of annotations (e.g. to
generate all cardiac parts that are known in the anatomy
ontology, in order to search the RDF store for all these
parts). Examples of reasoning-based queries are outlined
in Figure 4B, and the ToolKit section that follows refers
to online demo and tutorial materials that illustrate the
functionality of this reasoning module.
(d) The RICORDO ToolKit
The overall strategy of the RICORDO effort is to develop
and demonstrate the effectiveness of tools for the aca-
demic and industry communities to support interoperabil-
ity of DMRs using ontologies. To that end, RICORDO is
developing a framework of tools to address the require-
ments we have identified. In particular, we are developing
a comprehensive toolkit that facilitates (i) the creation of
composite terms, (ii) the annotation of DMR metadata
using either composite terms or individual terms from
selected reference biomedical ontologies, (iii) the semantic
integration of DMRs, and (iv) the retrieval of DMRs based
on complex queries over biomedical ontologies. Figure 5
presents schematically the ToolKit framework that (i)
enables the creation of composite terms from reference
ontologies, (ii) annotates resource metadata and (iii)
makes use of automated reasoning over ontologies.
Figure 5 Schematic overview of the RICORDO ToolKit
architecture. The RICORDO Toolkit is modular and consists of
several components. These components can be combined to
implement the workflow we envision for annotation of DMRs. The
Composite Component enables the creation of composite terms
and accesses and modifies the ontologies used by the RICORDO
ToolKit. The Annotation Component creates annotations of DMRs
and deposits them in the Metadata Store. The Query Component
combines reasoning over ontologies and access to the Metadata
Store to perform powerful and expressive queries over DMRs. The
Composite Component, Annotation Component, Query Component
and the Metadata Store are accessible to outside users either
directly or through the prototypical RICORDO demo application [64]
which integrates and combines the RICORDO Toolkit’s components.
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The RICORDO toolkit we are developing consists of
four core components:
1. The RICORDO Composite Component enables
the creation of composite terms based on the
RICORDO core ontologies. This component ensures
that the composite terms conform to the RICORDO
grammar. To make this complex grammar accessible
to users, we have identified and implemented several
commonly occurring definition patterns that serve as
templates for term creation.
2. The RICORDO Annotation Component enables
the creation of annotations of DMRs. In particular,
it creates the link between a composite term, or a
term in a reference ontology, and a DMR element. If
an annotation with a composite term is required,
and such a composite term does not exist already in
the knowledgebase, the RICORDO Composite Com-
ponent is used to create this complex term and sub-
sequently generate the annotation.
3. The RICORDO Metadata Store allows the storing
and integration of DMR metadata. It contains the
annotation triplets and makes them accessible via a
standard interface.
4. The RICORDO Query Component is the central
component for the retrieval of DMR metadata based
on the complex class descriptions contained in the
RICORDO core ontologies. The Query Tool makes
extensive use of automated reasoning over ontologies
and therefore enables complex and precise queries
over DMRs. We have implemented patterns to query
DMR metadata based on commonly used class defini-
tion patterns. The performance level achieved enables
real-time response to queries.
These components address some of the major aspects
of the RICORDO plan for interoperability of resources
in physiology as follows:
1) complex physiological phenomena can be
described using the Composite Component,
2) the above composite descriptions, or terms from
reference ontologies, can be attached to DMR ele-
ments using the Annotation Component,
3) the Metadata store will integrate these annota-
tions across different resources, domains and com-
munities, and
4) the Query Component will allow retrieval of these
annotations while combining knowledge from the
annotations and the biomedical ontologies developed
across communities.
For example, to annotate an element that represents
the “Volume of Pancreas” in a radiology resource (see
Figure 4B), the Composite Component of the RICORDO
Toolkit is first used to create a formal description of
“Volume of Pancreas” by combining information from
three biomedical reference ontologies. Specifically,
“Volume of Pancreas” combines the term “Volume”
from the PATO ontology of qualities, the relationship
“inheres_in” from the OBO Relationship Ontology [57],
and the anatomical term “Pancreas” from the FMA. Sec-
ond, the Annotation Component is used to link the
resource element and the corresponding composite term
in a triplet consisting of an identifier for the resource
element (in Figure 4B, this element is depicted to origi-
nate in a Radiology Report), a relation and a reference
to the composite term (in Figure 4B, this composite
term is identified by the number ‘34’). The link created
by the Annotation Component is subsequently deposited
in the Metadata Store. Using the Query Component of
the RICORDO Toolkit (Figures 4B and 5), this annota-
tion can be retrieved using complex queries over both
the composite terms and reference ontologies. For
example, it is possible to retrieve the annotation with
the composite “Volume of Pancreas” by querying for
“Size” that inheres in “Organs” (Figure 4B, Query_3).
To support software developers in (i) implementing the
standards and (ii) re-use the tool source code we are devel-
oping, we make the RICORDO Toolkit prototype freely
available on our website[58], under the Apache License
2.0. In addition, we have developed demonstration soft-
ware that implements all components of the RICORDO
Toolkit and enables users to explore the RICORDO func-
tionality (accessible through [59]). We also make a detailed
tutorial for using the RICORDO Toolkit available in our
website (see [59], documentation section]. Further avail-
able resources on the same webpage include project docu-
mentation reports (known as Deliverable Reports) as well
as links to community efforts that use RICORDO methods
and standards (also refer to the Use Cases section that
follows).
(e) RICORDO Use Cases
The RICORDO approach is already being applied to the
annotation of resources in three distinct areas, namely
the annotation of:
1) biomedical imaging ranging from (i) images (e.g.
radiology data in DICOM format [60]) to (ii) spatial
models (e.g. FieldML computational models [61],
geometric radiology models[62] and 3D gene expres-
sion atlases[63,64]);
2) predicted properties of molecular entities, in par-
ticular the output of machine-learning tools predict-
ing protein sequence subcellular localisation [65];
3) variables encoded in physiology models based on
ordinary differential equations (ODEs) (e.g. [8,39,66])
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that represent biophysical measurements relevant to
human biology.
Discussion and Conclusion
The RICORDO effort is based on formal knowledge
representation methods, including the use of ontologies,
and associated tools. This approach uses the explicit
representation of anatomical and medical knowledge in
the management of DMR annotation. These annotations,
which constitute the resource metadata, are statements
mapping ontology term identifiers onto resource element
identifiers. Ontologies facilitate machine processing, stan-
dardisation of resource metadata, as well as reasoning.
The resulting method allows the navigation and querying
of annotation repositories using formalized biomedical
knowledge. A consequence of this approach is that the
process of DMR documentation in the PPME domains is
more efficient and has a beneficial impact on resource
sharing, as well as fostering the development of commu-
nal documentation standards.
RICORDO primarily aims to support the management
of heterogeneous biomedical DMRs. The RICORDO fra-
mework will bring resources together through a com-
mon process of annotation. As a result, these resources
will form an ecosystem that can be navigated on the
basis of communal reference knowledge and meaning -
this is the operational definition of ‘resource semantic
interoperability’ in RICORDO.
The knowledge management workflow we are develop-
ing consists of three key steps. The first entails the crea-
tion of PPME resource annotation that is machine
processable and uses reference and standardised ontology
terms. This is followed by the storage of annotations in
repositories that are distinct and independent from those
containing the original resources. The final stage allows
the querying of annotations to retrieve references to rele-
vant resources. This step is enhanced by intermediate
domain ontological reasoning.
In this paper, we presented the RICORDO approach
applied to the management of clinical data and models
and outlined some of the advantages of managing clini-
cal resources with ontologies. The benefits of this
approach include the provision of:
1) unambiguous resource annotations;
2) machine processable annotations;
3) inferencing on annotations;
4) the use of biological knowledge in reasoning.
The above contribute directly to the overall goal of
RICORDO in supporting semantic interoperability of
biomedical DMRs through ontology-based annotation.
Achieving such a goal would (i) encourage more effective
navigation and re-use of clinical DMRs, as well as (ii) sus-
tain interoperability operations based on the criterion of
biological similarity. Such operations include activities
ranging from automated dataset matching to model mer-
ging and managing complex simulation workflows. This
aim is pursued through the:
1) standardisation of metadata, as well as of a core
set of reference ontologies for use in annotations;
2) provision of tools to extend and combine ontolo-
gies, and query annotations.
RICORDO therefore offers a number of potential
advantages to clinical data management by:
1) performing and maintaining annotation of
resources while respecting their integrity and confi-
dentiality constraints;
2) bridging clinical terminologies to ontology-based
semantics;
3) supporting semantic integration in the physiology
and clinical domains and, by extension, the semantic
interoperability of their DMRs.
The ongoing RICORDO effort is working closely with
knowledge representation and modelling communities to
support the development and adoption of semantic inter-
operability standards and technologies for biomedical
research. While the interoperability solutions emerging
from RICORDO are principally focused on multiscale
biological structure, processes and associated qualities,
the application of these solutions may be extended to any
domain that is supported by well-established standard
reference ontologies.
In addition, RICORDO will provide a metadata man-
agement system that extracts and serves annotations via
a separate repository service that does not require the
public availability of the DMR to which these annota-
tions were originally applied. In practice, therefore, this
system will allow users to make well-defined details of
their work known to the community, while satisfying
the constraints and obligations of confidentiality that
sensitive clinical or commercial work often entails. In
that sense, the RICORDO approach will make it easier
for the community to be aware of the presence of data-
sets or models that may be relevant to some biomedical
objective, despite the fact that the actual DMRs them-
selves may not be publicly available.
The next challenge for the RICORDO effort is to work
with both ontology and modelling communities to
establish appropriate training resources in support of
the adoption of semantic technologies. This step ensures
that users considering the adoption of the RICORDO
framework are able to match precisely their DMR inter-
operability requirements to the rewards and limitations
of available semantic solutions.
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